Results 1 to 10 of about 11,830 (161)

Diagnostic role of immunohistochemical markers CK19 and CD56 in thyroid neoplasms

MGM Journal of Medical Sciences, 2023
Introduction: Thyroid cancer is the most common type of endocrine cancer, with an increasing prevalence. The possibility of a malignant neoplasm is the primary concern in people with thyroid nodules. The presence of a plethora of variants complicates the
Pallavi Priyadarshini, Manoj Kumar Patro, Prasanta Kumar Das   +2 more
doaj   +2 more sources

Expression of CK19 and KIT in resectable pancreatic neuroendocrine tumors

Tumor Biology, 2013
The objectives of this study were to validate the immunohistochemical expression patterns of CK19 and KIT in primary pancreatic neuroendocrine tumors (pNETs) and to verify the potential biomarkers that can be used to predict the clinical behaviors and postoperative outcomes.
Wenhui Lou, Xu Han, Yuan Ji
exaly   +3 more sources

Combination with CK19 Might Increase the Prognostic Power of Hep Par 1 in Hepatocellular Carcinoma after Curative Resection

Journal of Investigative Surgery, 2018
Purpose: Hepatocyte Paraffin 1 (Hep Par 1) and cytokeratin 19 (CK19) were shown to be associated with post-surgical prognosis of hepatocellular carcinoma (HCC). However, further validation might be needed.
Li Zhou, Zhiyong Liang
exaly   +2 more sources

Silencing CK19 regulates ferroptosis by affecting the expression of GPX4 and ACSL4 in oral squamous cell carcinoma in vivo and in vitro

Scientific Reports
To analyze the mechanism of how interfering with the cytokeratin 19 (CK19) pathway via the ferroptosis pathway affects tumor biological behaviors in the process of oral squamous cell carcinoma (OSCC) development.
Yong Rao, Jingying Li, Lijuan Shi, Xiao Chen, Yun Hu, Yalin Mao, Xiaoyan Zhang, Xuqian Liu   +7 more
exaly   +2 more sources

Elevated expression of CK19, Ki67, and β-Catenin as prognostic biomarkers in hepatocellular carcinoma

BMC Cancer
Background Cytokeratin 19 (CK19), Ki67 antigen (Ki67), and β-catenin are abnormally overexpressed in hepatocellular carcinoma (HCC), but their diagnostic and prognostic value remains unclear.
Hongjiu Yu, Jiaying Wu, Lianghui Gao
doaj   +3 more sources

CK19-positive Hepatocellular Carcinoma is a Characteristic Subtype [PDF]

Journal of Cancer, 2020
The heterogeneity of hepatocellular carcinoma (HCC) commonly leads to therapeutic failure of HCC. Cytokeratin 19 (CK19) is well acknowledged as a biliary/progenitor cell marker and a marker of tumor stem cell. CK19-positive HCCs demonstrate aggressive behaviors and poor outcomes which including worse overall survival and early tumor recurrence after ...
Zhuo, Jian-Yong, Lu, Di, Tan, Win-Yen, Zheng, Shu-Sen, Shen, You-Qing, Xu, Xiao   +5 more
openaire   +2 more sources

Prognostic Factors in Thyroid Papillary Microcarcinoma

Journal of Contemporary Medicine, 2023
Aim: Our aim in this retrospective study is to evaluate the factors that are important in the prognosis of thyroid papillary microcarcinoma. Material and Method: This study is a retrospective study.
Sezgin Zeren, Gizem Akkaş Akgün
doaj   +1 more source

Individual and joint influence of cytokeratin 19 and microvascular invasion on the prognosis of patients with hepatocellular carcinoma after hepatectomy

World Journal of Surgical Oncology, 2022
Background and objectives To evaluate the individual and combined associations of cytokeratin 19 (CK19) and microvascular invasion (MVI) with prognosis of patients with hepatocellular carcinoma (HCC). Methods Clinicopathological data on 352 patients with
Shang-Dong Qin, Jie Zhang, Ya-Peng Qi, Jian-Hong Zhong, Bang-De Xiang   +4 more
doaj   +1 more source

The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib

Cell Death and Disease, 2021
Cytokeratin 19-positive (CK19+) hepatocellular carcinoma (HCC) is an aggressive subtype characterized by early recurrence and chemotherapy tolerance. However, there is no specific therapeutic option for CK19+ HCC. The correlation between tumor recurrence
Jianyong Zhuo, Di Lu, Zuyuan Lin, Xinyu Yang, Modan Yang, Jianguo Wang, Yaoye Tao, Xue Wen, Huihui Li, Zhengxing Lian, Beini Cen, Siyi Dong, Xuyong Wei, Haiyang Xie, Shusen Zheng, Youqing Shen, Xiao Xu   +16 more
doaj   +1 more source

Metastatic Collision Tumour (Papillary Thyroid Carcinoma and Squamous Cell Carcinoma) in Cervical Lymph Nodes: An Immunohistochemical Analysis [PDF]

Journal of Clinical and Diagnostic Research, 2016
Collision tumours are a rare entity, in this report, we describe a case of 73-year-old woman presented with a rapid enlargement of left upper cervical lymph node (LN) associated with right thyroid nodular goiter. The histopathological examination of the
Alshimaa Mahmoud Alhanafy, Dalia Al-Sharaky, Asmaa Gaber Abdou, Rania Abdallah Abdallah   +3 more
doaj   +1 more source